Form Health Review
We track Form Health but publish no price for it, and this page explains exactly why.
Form Health does not publish a semaglutide price we can interpret and verify from its own material, so we publish none. A figure copied from a third-party round-up without a capture date is not a price, it is a rumour with a dollar sign.
That is not an accusation. Programmes price behind an intake for ordinary commercial reasons. But a comparison site exists to make cost visible before you commit, and a programme that reveals cost only after you have handed over contact details and a health history has opted out of that comparison.
We track this programme but could not verify a compounded semaglutide price from its own published material. We publish no figure rather than repeat one we cannot check.
Source
No verified price as of 2026-08-05
Of the 32 programmes on this site, 4 have a price we read at the provider or manufacturer, 16 carry a third-party figure we have not confirmed, and 12 publish no price we can interpret. Every table shows which is which, because a comparison that mixes them without saying so is not a comparison.
First-year all-in cost
What to ask Form Health before you give them anything
- What is the total monthly cost at a 2.4 mg maintenance dose, including every fee?
- Does that figure change as the dose escalates?
- Is there a membership, consultation, shipping or laboratory charge on top?
- Which compounding pharmacy fills the prescription, by name and state licence?
- Is the prescribing clinician licensed in my state?
- What notice is required to cancel, and what is refundable before shipment?
Answers to those six in writing amount to published pricing, and we will record them here with the date. Send them through contact.
Why a missing price is itself information
A programme that publishes a price is making a claim it can be held to. A programme that reveals cost only after an intake has made a commercial choice: it wants contact details and a medical history before you can compare it against anything. That is legal and common, and worth noticing.
It also makes an honest comparison impossible. Every figure on this site is stated all-in at a named dose, and there is no way to place Form Health on that axis without a number from Form Health.
What the alternatives publish
The cheapest tracked route, NexLife, publishes $145 a month all-in at a 2.4 mg maintenance dose and about $1,740 for a first year. Several publish a full ladder from the starter dose to the ceiling. Those figures can be checked against the provider's own page in under a minute, which is the standard Form Health is being measured against.
What we will not do
Estimate. Several comparison sites carry figures for programmes that publish none, generally by copying an older round-up that copied an earlier one. That is how a promotional rate from two years ago becomes a current price, and it is the most common error in this category.
A blank row is less useful than a number and considerably more honest than a wrong one.
Programmes that do publish a price
Every other programme in our directory states a figure we could capture at at least one dose tier. The cheapest verified all-in cost at a maintenance dose is $145 a month.
How the price behaves as your dose climbs
Form Health starts at — and rises with your prescription, reaching — at 2.4 mg. The advertised figure therefore describes roughly four weeks of a twelve-month course. Budget from the 2.4 mg row, because that is where most of your year happens.
Dose-scaled pricing is not misconduct — more active drug does cost a compounder more. But it means your bill rises exactly as the dose starts working, which inverts the incentive you face and is invisible in any table quoting one number.
What a longer horizon costs here
Treatment on this drug class is realistically a multi-year commitment, because the withdrawal evidence shows substantial regain after stopping. These are the numbers worth deciding on.
| If you maintain at | Per month | One year | Three years |
|---|
Commitment, refunds and what is at risk
No discounted prepaid term is published, which cuts both ways: no lower rate for committing, and no money at risk before you know whether you tolerate the drug. For a first three months that is the safer structure.
Cancellation: not published. Two questions to get in writing before paying anything: does the quoted rate hold at renewal, and what happens if a clinician stops your prescription mid-term.
What this programme does not publish
Measured against our published criteria, Form Health does not publish: price published at every dose tier; price does not rise as the dose escalates; dispensing pharmacy or prescriber named before purchase; no separate recurring membership fee; prepaid term and its rate published; cancellation terms published. Each is a question you can ask before enrolling, and a programme that answers in writing has told you something useful about how it operates.
Naming the dispensing pharmacy carries the most weight of the seven, because it is the only one that lets you check a public state board register yourself before injecting something weekly. Fewer than a fifth of the programmes we price do it.
Seven questions before you enrol
- What is the total in month six at 2.4 mg, including every fee?
- Which compounding pharmacy fills the prescription, by name and state licence?
- Is the prescribing clinician licensed in my state?
- What is the vial concentration and the beyond-use date?
- Does the quoted rate hold at renewal, or revert?
- What happens if a shipment arrives warm, and who pays for the replacement?
- What notice is required to cancel, and what is refundable before shipment?
None requires clinical training and all are answerable before you pay. A programme that deflects the pharmacy question has answered it.
Using it well if you do enrol
Fix a weekly injection day and keep it. Record dose, date and injection site each week. Photograph any shipment that arrives warm before opening it further. Diary the renewal date if an introductory rate applies. And re-price the market annually at your actual maintenance dose — no programme tells existing patients when a competitor drops below it.
The short version of form health
Price the dose you expect to hold, not the one in the advertisement. Add every recurring fee. Verify the pharmacy. Everything else on this page is detail underneath those three.
Done properly the answer is usually one of a handful of programmes: the cheapest verified route runs $145 a month all-in, about $1,740 across a first year including titration.
The next step that actually moves things
Send two or three programmes the same five questions: total at 2.4 mg including every fee, which pharmacy, is the prescriber licensed in my state, what notice to cancel and what is refundable, and which form of the active ingredient is used.
Whoever answers all five in writing has told you more than any comparison table can, this one included. Whoever does not has also told you something.
One thing worth doing annually
Re-price the market at your actual maintenance dose. No programme notifies existing patients when a competitor drops below it, and semaglutide pricing moved repeatedly through 2025 and 2026 — manufacturer cuts, an oral option, a higher-dose product, and several platforms leaving compounded entirely.
An hour once a year is a poor use of time for most purchases and an excellent one for a medication you may take for years.
Reading this alongside the rest of the site
Pricing pages isolate one component. Provider reviews carry the whole record for one programme. Comparisons run two side by side at every dose. The rankings sort the same dataset on different questions. None is the whole picture and none is meant to be.
If you read one other page, make it how to verify a pharmacy. Price is the easiest thing to compare and rarely the thing that goes wrong.
What we would need to change our mind
A programme publishing a figure at a dose tier currently blank. A named dispensing pharmacy with a checkable licence. A pricing model changing in either direction. A regulatory action. Or a correction from a reader with a source we can open.
All five are logged with the date they landed, on the change log and in the dataset. Prices here were captured 2026-08-05.
What this site will not do
Publish an estimated price for a programme that does not publish one. Rank a programme higher because it pays. Present a compounded preparation as equivalent to an approved product. Or carry a figure without the date it was captured.
Those four rules cost us pages, rankings and revenue, and they are the only reason a reader has to prefer this to a round-up assembled in an afternoon. A price without its date is not a fact, and a comparison built from undated prices is not a comparison.
Who this site is not for
Anyone with coverage under a documented indication, who should use it rather than read a cash comparison. Anyone looking for a source without a prescription, which this site will not help with. And anyone wanting a single confident recommendation, because the honest answer depends on your dose, your coverage and your tolerance for commitment.
If you want the short version anyway: price the dose you will hold, add every fee, verify the pharmacy, and avoid long prepaid terms until you have tolerated a maintenance dose for a cycle.
Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.
Compare every programme on one screen
The matrix carries all-in price at every dose, fee structure, commitment terms, pharmacy disclosure and verification status for every programme we track.